Rx4good

What Rx4good does

Rx4good is a privately held, woman-owned patient advocacy and engagement consultancy founded in 2009 and headquartered in the United States (firmographic data lists Jacksonville, FL; the company website does not specify a city). The firm serves pharmaceutical and biotechnology companies, government and regulatory bodies, academic medical centers, and nonprofit patient advocacy organizations, helping clients embed patient perspectives into clinical development, communications, policy advocacy, and coalition-building activities. Its therapeutic-area footprint spans cardiology, hematology, oncology, ophthalmology, neurosciences, pain, pediatrics, respiratory, transplantation, rare diseases, and women's health.

Rx4good's core service offering is strategic counsel and program implementation rather than a software product. Its central differentiator is a proprietary stakeholder mapping methodology known as the 4 R's framework (Reach, Relevance, Reputation, Relationship), developed in-house and applied across hundreds of mappings in 33 countries. Adjacent offerings include the Caregiver Factor research initiative (70+ nonprofit partners), the Prioritizing Every Patient (PEP) Research Fellowship (launched December 2020), biomarker education resources produced with Foundation Medicine (2023), and the Good4Patients newsletter. Rx4good also facilitates the Rare & Ready Coalition, formed in 2022 with 115 nonprofit member organizations focused on rare disease policy and access.

The business model is straightforward professional services: custom, quote-based consulting and advisory engagements billed to enterprise pharma and biotech clients, with secondary revenue from government, academic, and nonprofit engagements. Distribution is direct via consultative sales, referrals, industry conferences (DIA, ASCO), and thought-leadership content. The company has disclosed no funding rounds, operates without a parent company, and remains independently owned. Recent leadership moves include the January 2026 appointment of Adam Pawluk as President, with founder Ann Moravick continuing in a strategic guidance capacity.

Name

Rx4good

Legal name

Rx4good, LLC

Website

https://rx4good.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Rx4good is a privately held, woman-owned patient advocacy and engagement consultancy founded in 2009, serving pharmaceutical, biotech, government, academic, and nonprofit clients through strategic counsel, proprietary stakeholder mapping (the 4 R's methodology), and coalition-building across 33 countries.

Ownership category

akta.pro rank

Product category

Healthcare Patient Advocacy Consulting

NAICS

Management Consulting Services (54161), Research and Development in the Social Sciences and Humanities (54172)

SIC

Services-Management Consulting Services (8742), Services-Health Services (8000)

akta.pro primary industry

Patient Education, Content & Personalized Journey Orchestration (HLACAEAE)

Keywords

• Patient advocacy consulting
• Stakeholder mapping
• Patient engagement services
• Healthcare advisory
• Pharmaceutical consulting

Headquarters

HQ city

Jacksonville

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations, Others

Revenue model

1. Consulting and Advisory Services: Rx4good generates revenue through professional service fees for patient advocacy consulting, strategic counsel, research, stakeholder mapping, and engagement program implementation. Services are billed to pharmaceutical companies, biotech firms, government agencies, and nonprofits.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Rx4good is a patient advocacy and engagement consultancy that counsels pharmaceutical, biotech, government, academic, and nonprofit clients on integrating patient perspectives into drug development, clinical trials, and commercial strategy. Core deliverables include strategic counsel, proprietary stakeholder mapping using the 4 R's framework (Reach, Relevance, Reputation, Relationship), patient-engagement research, coalition facilitation, and program implementation. The firm supplements paid advisory work with research initiatives, educational resources, and the Good4Patients thought-leadership newsletter.

Product overview

Rx4good is a woman-owned patient advocacy and engagement consultancy founded in 2009. The company operates as a single unified service offering—strategic consulting services—not a software platform. Its portfolio includes patient advocacy consulting, stakeholder mapping using the 4 R's methodology, research services (including the Caregiver Factor Survey and PEP Research Fellowship), educational resources, and the Good4Patients newsletter. Rx4good also facilitates the Rare & Ready Coalition, a coalition of 115 nonprofit member organizations focused on rare disease advocacy.

Differentiator

Problem solved

Functional benefit

Products and services

• Patient Advocacy and Engagement Consulting Services Strategic consulting services that help pharmaceutical companies, biotech firms, patient organizations, government agencies, and academic institutions put patients first in their advocacy, communications, and engagement efforts. Engagements span cardiology, hematology, oncology, ophthalmology, neurosciences, pain, pediatrics, respiratory, transplantation, rare diseases, and women's health.
• Stakeholder Mapping (4 R's Methodology) Competitive intelligence service using Rx4good's proprietary 4 R's methodology (Reach, Relevance, Reputation, Relationship) to evaluate patient organizations and map the patient ecosystem for strategic partnership decision-making. Built on hundreds of mappings spanning 33 countries.
• Caregiver Factor Research Multi-stakeholder research initiative studying the role of caregivers in medical decision-making and clinical trial participation, conducted in collaboration with 70+ advocacy organizations with survey of more than 600 caregivers. Findings have been presented at the Drug Information Association (DIA) annual meeting.
• Rare & Ready Coalition Coalition of 115 nonprofit member organizations working together to improve the lives of the rare disease community through advocacy, education, and policy action in areas including newborn screening, prescription drug affordability, and patient access. Formed by Rx4good in collaboration with clients in 2022.
• Prioritizing Every Patient (PEP) Research Fellowship Research fellowship initiative focused on developing diversity and inclusion resources to address healthcare disparities, with Rx4good providing program design, research direction, and partner coordination.

Quantifiable outcome

• 91% of caregivers report being 'very involved' in medical decisions in Rx4good's Caregiver Factor Survey
• +2 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Twelve partnerships are on record, tiered core.

• Foundation MedicinecoreStrategic or Co-development Partner · 1 January 2023Rx4good compiled biomarker education resources in partnership with Foundation Medicine's 2023 Patient Advocacy Summit. Leading patient advocacy partners who participated in the summit contributed to developing these education resources.
• Digital Therapeutics AlliancecoreStrategic or Co-development Partner · 1 January 2023Rx4good collaborated with the Digital Therapeutics Alliance on research examining patient and caregiver interest in digital therapeutics. Findings were presented at the inaugural DTA Summit in Washington, DC.
• Rare & Ready CoalitioncoreStrategic or Co-development Partner · 1 January 2022Formed in 2022 through collaboration between Rx4good and clients. Includes 115 nonprofit member organizations working together to improve lives of the rare disease community through advocacy, education, and policy action in areas including newborn screening, prescription drug affordability, and patient access.
• American Heart AssociationcoreStrategic or Co-development Partner · 1 January 2018One of 70+ nonprofit organizations that partnered with Rx4good on the Caregiver Factor research initiative to study the role of caregivers in medical decision-making.
• American Cancer SocietycoreStrategic or Co-development Partner · 1 January 2018One of 70+ nonprofit organizations that partnered with Rx4good on the Caregiver Factor research initiative.
• CancerCarecoreStrategic or Co-development Partner · 1 January 2018One of 70+ nonprofit organizations that partnered with Rx4good on the Caregiver Factor research initiative.
• Caregiver Action NetworkcoreStrategic or Co-development Partner · 1 January 2018One of 70+ nonprofit organizations that partnered with Rx4good on the Caregiver Factor research initiative.
• Epilepsy FoundationcoreStrategic or Co-development Partner · 1 January 2018One of 70+ nonprofit organizations that partnered with Rx4good on the Caregiver Factor research initiative.
• Global GenescoreStrategic or Co-development Partner · 1 January 2018One of 70+ nonprofit organizations that partnered with Rx4good on the Caregiver Factor research initiative.
• National Alliance for CaregivingcoreStrategic or Co-development Partner · 1 January 2018One of 70+ nonprofit organizations that partnered with Rx4good on the Caregiver Factor research initiative. Also collaborated on the 2017-2018 National Rare Diseases Caregiver Survey.
• National Alliance on Mental Illness (NAMI)coreStrategic or Co-development Partner · 1 January 2018One of 70+ nonprofit organizations that partnered with Rx4good on the Caregiver Factor research initiative.
• National Stroke AssociationcoreStrategic or Co-development Partner · 1 January 2018One of 70+ nonprofit organizations that partnered with Rx4good on the Caregiver Factor research initiative.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Market position

Competitive moat4 records

Key highlights6 records

Customer concentration

• Xx.com/rx4good

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rx4good